Moreover, CML-EVs, packaged with miR-126, have been found to negatively regulate the expression of VCAM-1 and CXCL12 in endothelial cells, thereby restricting CML motility and adhesion [159,164]. Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.